Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • US House passes debt ceiling bill in crucial step to avert historic default
    • Earth past its safe limits for humans, scientists say
    • ‘People rot from the inside out’: lethal xylazine deepens the US drug crisis
    • Eurozone inflation falls to lowest level since Russia invaded Ukraine
    • Into the bunker: drone attacks bring war home to Russia
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • UK house prices extend falls as mortgage repayments soar
    • Insurer for English barristers paid £750,000 to own director to fight cases
    • Boris Johnson hands over messages and diaries to government
    • UK should boost alignment of rules with EU, says business commission
    • Teesside mayor struck secret deal to transfer Hartlepool property
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • US-China tensions have upended global order, Jamie Dimon warns
    • ‘Everyone will get affected’: Tesla jolts EV charging industry
    • ‘Ultimate decider’ on Jeffrey Epstein was JPMorgan’s ex-top lawyer, says Jamie Dimon
    • Exxon and Chevron shareholders cut support for climate resolutions
    • Diddy-owned drinks company sues Diageo alleging racial discrimination
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Live news: Macy’s and Dollar General warn on US consumer spending
    • Live news updates from May 31: Macron backs Nato ‘path’ for Ukraine, US jobs openings jump
    • Opec bans prominent media groups from Vienna meeting
    • Exxon and Chevron shareholders cut support for climate resolutions
    • Monzo increases bad loan provisions after buy now, pay later push
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Game, set and almost match to Biden on the debt ceiling
    • How the Thatcherites lost their Brexit dream and their party
    • We should stop worshipping at the altar of convenience
    • Why DeSantis is losing Republicans to Trump
    • Fixing Britain’s broken housing market
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • ‘Everyone has the right to completely log off’: what bosses think about the right to disconnect
    • Wellcome Leap’s Regina Dugan: ‘Odds are irrelevant, if what you’re trying to do is important’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Trump or not, US meltdown could be inevitable
    • Bruce Springsteen battles mortality in three-hour Edinburgh show
    • Porsche, Bentley, Armani: Why Miami can’t build enough branded high rises
    • The UK’s best bakeries: the readers’ picks
    • Dyson’s new wheeze? An air purification system you wear on your head
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Wellcome Trust

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Sunday, 28 May, 2023
    InterviewLeadership
    Wellcome Leap’s Regina Dugan: ‘Odds are irrelevant, if what you’re trying to do is important’

    The former head of the US defence department’s research agency was behind big bets on mRNA technology

  • Friday, 5 May, 2023
    Wellcome Trust to triple size of Cambridge genome campus

    Biggest biomedical charity makes first investment in science infrastructure from its endowment

  • Tuesday, 10 January, 2023
    Wellcome vows to boost spending even if endowment has to be tapped

    Charity’s chair Julia Gillard commits to £16bn investment in science and health over next decade

  • Wednesday, 10 August, 2022
    Racial equality
    Wellcome vows action to counter its ‘institutional racism’

    Medical charity will introduce funding stream aimed at black and minority researchers

  • Tuesday, 18 January, 2022
    Bill Gates
    Bill Gates warns of pandemics potentially far worse than Covid

    Philanthropist calls on governments to contribute billions to tackle future pathogens and increase vaccine supplies

  • Tuesday, 11 January, 2022
    Medical science
    Wellcome Trust in £16bn spending pledge as world prepares for endemic Covid

    Top UK medical charity to focus on next generation vaccines as it warns of complacency over future variants

  • Tuesday, 2 November, 2021
    Coronavirus
    Wellcome director resigns as UK government science adviser

    Jeremy Farrar calls Covid-19 picture ‘concerning’ but insists he is not leaving Sage as a protest

  • Tuesday, 15 December, 2020
    Medical science
    Wellcome Trust hails ‘spectacular year’ for science

    Medical charity’s endowment boosted investments in research, much of it tied to pandemic

  • Friday, 6 November, 2020
    UK property
    Wellcome Trust to buy developer Urban&Civic for £506m

    Medical charity commits to long-term investment in regeneration-focused housebuilding

  • Monday, 19 October, 2020
    Disease control and prevention
    How to spread the word about antibiotic resistance

    The FT is working with the Wellcome Trust to raise awareness of a growing threat

  • Thursday, 20 August, 2020
    Coronavirus: free to read
    Why is the ‘anti-vaxxer’ movement growing during a pandemic?

    US concerns that Trump will rush to approve a vaccine before election is playing into wider safety fears

  • Thursday, 25 June, 2020
    News in-depthCoronavirus treatment20 min
    Coronavirus: the global race for a vaccine | FT Interview

    The Wellcome Trust's Jeremy Farrar on the prospects for a Covid-19 vaccine

  • Thursday, 14 May, 2020
    Wellcome goes global and appoints Julia Gillard as next chair

    Former Australian prime minister will be first non-Briton to head UK’s biggest charity

  • Tuesday, 7 April, 2020
    Impact investing
    Wellcome seeks $8bn from business to fight coronavirus

    Research group launches ‘Covid-zero’ to fund hunt for vaccines, treatments and testing

  • Monday, 30 March, 2020
    Coronavirus
    Gates Foundation and Wellcome Trust to fund Covid-19 drug trials 

    Accelerator fund will test whether existing drugs such as chloroquine can treat coronavirus

  • Tuesday, 10 March, 2020
    Coronavirus
    Gates Foundation and Wellcome set up $125m coronavirus drug fund

    Research foundations join forces with Mastercard-backed charity to develop treatments

  • Thursday, 23 January, 2020
    Miranda Wolpert
    Stop throwing money at mindfulness apps, puppies and yoga

    Mental wellbeing is a critical business issue and we should treat it as one

  • Wednesday, 15 January, 2020
    Science
    Lab workers complain of long hours, bullying and stress

    Wellcome study reveals ‘shocking portrait of research environment’

  • Sunday, 5 May, 2019
    Pilita Clark
    The dream of a four-day week needs a lot more work

    A big employer has cancelled plans to pilot shorter hours, citing business disruption

  • Sunday, 21 April, 2019
    Pharmaceuticals sector
    We ignore the disaster in the antibiotics market at our peril

    There is no viable path for new drugs, however valuable they are to society

  • Wednesday, 27 March, 2019
    Drugs research
    Industry must turn words into action on superbugs, says Jim O’Neill

    Biotech companies need big pharma to bring innovative antibiotics to market

  • Friday, 8 March, 2019
    Drugs research
    King’s and Wellcome sign US deal to develop painkillers

    Merck collaboration for new generation of pills could be worth as much as $340m

  • Sunday, 9 September, 2018
    The FT ViewArtificial intelligence
    Artificial intelligence must avoid a backlash

    Governments and scientists need to co-operate to educate the public

  • Friday, 17 August, 2018
    Pharmaceuticals sector
    Wellcome sanctions top cancer scientist over bullying allegations

    Charity will terminate £3.5m worth of grants to Nazneen Rahman

  • Monday, 9 July, 2018
    UK business & economy
    Wellcome launches £250m Leap Fund to back risky research

    Britain’s wealthiest foundation to support bold ideas from universities and businesses

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In